Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 -9.81%
December 31, 2025 -3.90%
September 30, 2025 97.23%
June 30, 2025 97.96%
March 31, 2025 99.84%
December 31, 2024 89.09%
September 30, 2024 19.07%
June 30, 2024 -727.0%
March 31, 2024 -233.7%
December 31, 2023 -72.73%
September 30, 2023 -6.79K%
June 30, 2023
March 31, 2023
December 31, 2022
September 30, 2022
Date Value
June 30, 2022
March 31, 2022
December 31, 2021 98.49%
September 30, 2021
June 30, 2021 0.00%
March 31, 2021
December 31, 2020
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019 0.00%
September 30, 2019 0.00%
June 30, 2019 0.00%
March 31, 2019 0.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Incyte Corp. 92.57%
Nurix Therapeutics, Inc. 57.43%
ACADIA Pharmaceuticals, Inc. 90.81%
Alnylam Pharmaceuticals, Inc. 76.88%
Anika Therapeutics, Inc. 65.15%

Gross Profit Margin (Quarterly) Related Metrics